Last reviewed · How we verify
PA5108 Latanoprost FA SR Ocular Implant — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
PA5108 Latanoprost FA SR Ocular Implant (PA5108 Latanoprost FA SR Ocular Implant) — PolyActiva Pty Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PA5108 Latanoprost FA SR Ocular Implant TARGET | PA5108 Latanoprost FA SR Ocular Implant | PolyActiva Pty Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PA5108 Latanoprost FA SR Ocular Implant CI watch — RSS
- PA5108 Latanoprost FA SR Ocular Implant CI watch — Atom
- PA5108 Latanoprost FA SR Ocular Implant CI watch — JSON
- PA5108 Latanoprost FA SR Ocular Implant alone — RSS
Cite this brief
Drug Landscape (2026). PA5108 Latanoprost FA SR Ocular Implant — Competitive Intelligence Brief. https://druglandscape.com/ci/pa5108-latanoprost-fa-sr-ocular-implant. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab